In vitro evaluation of double-carbapenem combinations against OXA-48-producing Klebsiella pneumoniae isolates using time–kill studies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vitro evaluation of double-carbapenem combinations against OXA-48-producing Klebsiella pneumoniae isolates using time–kill studies
Authors
Keywords
-
Journal
JOURNAL OF MEDICAL MICROBIOLOGY
Volume 67, Issue 5, Pages 662-668
Publisher
Microbiology Society
Online
2018-03-21
DOI
10.1099/jmm.0.000725
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae
- (2017) M. Souli et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- In VitroSusceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)
- (2016) Boudewijn L. M. de Jonge et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Klebsiella pneumoniae co-producing OXA-48, CTX-M-15, and ArmA in Greece
- (2016) I. Galani et al. CLINICAL MICROBIOLOGY AND INFECTION
- Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods
- (2016) Chang-Ro Lee et al. Frontiers in Microbiology
- Genetic and Biochemical Characterization of OXA-405, an OXA-48-Type Extended-Spectrum β-Lactamase without Significant Carbapenemase Activity
- (2015) Laurent Dortet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitroevaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae
- (2015) Laurent Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treating infections caused by carbapenemase-producing Enterobacteriaceae
- (2014) L.S. Tzouvelekis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections
- (2014) A. Oliva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of Humanized Carbapenem and Ceftazidime Regimens against Enterobacteriaceae Producing OXA-48 Carbapenemase in a Murine Infection Model
- (2013) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Broad-Spectrum β-Lactam Antibiotics for Treating Experimental Peritonitis in Mice Due to Klebsiella pneumoniae Producing the Carbapenemase OXA-48
- (2012) Olivier Mimoz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
- (2012) C. Navarro-San Francisco et al. CLINICAL MICROBIOLOGY AND INFECTION
- Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak
- (2012) J. R. Pano-Pardo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OXA-48-like carbapenemases: the phantom menace
- (2012) L. Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- First Clinical Cases of OXA-48-Producing Carbapenem-Resistant Klebsiella pneumoniae in the United States: the "Menace" Arrives in the New World
- (2012) A. J. Mathers et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
- (2011) Catharine C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Crystal Structure of the OXA-48 β-Lactamase Reveals Mechanistic Diversity among Class D Carbapenemases
- (2009) Jean-Denis Docquier et al. CHEMISTRY & BIOLOGY
- Pharmacokinetic and Pharmacodynamic Properties of Meropenem
- (2008) David P. Nicolau CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More